Sequences

Sample result

SIINFEKL, an exact peptide

A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.

Patents

2,028 publications in 1,357 families match these filters.

  1. US 11510996-B22022-11-29

    Covalent polymer-antigen conjugated particles

    COUR PHARMACEUTICALS DEVELOPMENT COMPANY INC. and THE REGENTS OF THE UNIVERSITY OF MICHIGAN

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  2. IMMUNE INDUCER CONTAINING POLYNUCLEOTIDE-PEPTIDE CONJUGATE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME

    The University of Kitakyushu

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 2 to 9. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   2 SIINFEKL 9
    

    8 of 8 identical, no gaps.

  3. MRNA TREATMENT NANOPARTICLES

    NUTCRACKER THERAPEUTICS, INC

    Query Match 100.0%Identity 100.0%Family of 4

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 4

    Grouped by the same title and applicant. No priority claim is on record.

  4. SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION

    Bayer Aktiengesellschaft

    Query Match 100.0%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 8, hit 18 to 25. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   18 SIINFEKL 25
    

    8 of 8 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  5. US 11547748-B22023-01-10

    Adoptive t-cell therapy

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   258 SIINFEKL 265
    

    8 of 8 identical, no gaps.

  6. JP 2023500799-A2023-01-11

    CAL-T CONSTRUCTS AND USES THEREOF

    TRUSTEES OF BOSTON UNIVERSITY,THE GENERAL HOSPITAL CORPORATION

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by a shared priority claim, US 62/916924.

  7. JP 2023502400-A2023-01-24

    STIMULI THAT HYPERACTIVATE RESIDENT DENDRITIC CELLS FOR CANCER IMMUNOTHERAPY

    THE CHILDREN'S MEDICAL CENTER CORPORATION

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  8. JP 2023014162-A2023-01-26

    TREATENT OF OVARIAN CANCER WITH ANTI-CD47 AND ANTI-PD-L1

    FORTY SEVEN, INC

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  9. JP 2023503427-A2023-01-30

    Hyperactive Dendritic Cells Enable Durable Adoptive Cell Transfer-Based Anti-Tumor Immunity

    THE CHILDREN'S MEDICAL CENTER CORPORATION

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  10. Novel cell-penetrating peptides and uses thereof

    Azothbio Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 17 to 24. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   17 SIINFEKL 24
    

    8 of 8 identical, no gaps.

  11. JP 2023505294-A2023-02-08

    Vaccine Conjugates

    Ultimovacs AB

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 6 to 13. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit    6 SIINFEKL 13
    

    8 of 8 identical, no gaps.

  12. WO 2023013785-A2023-02-09

    Nucleic acid construct utilizing SNARE

    KAO CORPORATION

    Query Match 100.0%Identity 100.0%Family of 7

    Best alignment and family

    Query 1 to 8, hit 413 to 420. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   413 SIINFEKL 420
    

    8 of 8 identical, no gaps.

    Family of 7

    Grouped by a shared priority claim, JP 2021-130022.

  13. JP 2023505747-A2023-02-13

    Methods for detecting immune response

    Alfred Health, The Macfarlane Burnet Institute for Medical Research and Public Health Ltd, Monash University

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 257 to 264. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   257 SIINFEKL 264
    

    8 of 8 identical, no gaps.

  14. JP 2023506381-A2023-02-16

    RECOMBINANT POLYPEPTIDES FOR PROGRAMMING EXTRACELLULAR VESICLES

    MCMASTER UNIVERSITY,OTTAWA HOSPITAL RESEARCH INSTITUTE

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   258 SIINFEKL 265
    

    8 of 8 identical, no gaps.

  15. SARS-COV-2 VACCINES

    GRITSTONE BIO, INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 37 to 44. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   37 SIINFEKL 44
    

    8 of 8 identical, no gaps.

  16. US 11590214-B22023-02-28

    Antigen presenting scaffolds for immune-cell manipulation

    Danmarks Tekniskte Universitet

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  17. BISPECIFIC MOLECULES FOR SELECTIVELY MODULATING T CELLS

    DANA-FARBER CANCER INSTITUTE, INC

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  18. JP 2023029997-A2023-03-07

    Envelope Virus Platform PeptiENV

    Valo Therapeutics

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 7 to 14. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit    7 SIINFEKL 14
    

    8 of 8 identical, no gaps.

  19. JP 2023030043-A2023-03-07

    Patent application sequence for JP 2023030043-A/10

    AMSilk GmbH

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 580 to 587. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   580 SIINFEKL 587
    

    8 of 8 identical, no gaps.

  20. EXTRACELLULAR VESICLES WITH IMPROVED HALF-LIFE

    EVOX THERAPEUTICS LTD

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 115 to 122. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   115 SIINFEKL 122
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  21. WO 2023033124-A2023-03-09

    ANTIGEN PRESENTING EXTRACELLUAR VESICLES, COMPOSITIONS COMPRISING THEREOF, AND METHODS FOR MANUFACTURING THEREOF

    NATIONAL UNIVERSITY CORPORATION KANAZAWA UNIVERSITY, NISSAN CHEMICAL CORPORATION

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 21 to 28. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   21 SIINFEKL 28
    

    8 of 8 identical, no gaps.

  22. JP 2023510308-A2023-03-13

    METHODS OF MAKING TOLEROGENIC DENDRITIC CELLS

    MODERNA TX INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  23. JP 2023510986-A2023-03-15

    MULTISPECIFIC ANTIBODIES FOR USE IN TREATING DISEASES

    YEDA RESEARCH AND DEVELOPMENT CO LTD

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  24. IMMUNOGENIC CONSTRUCTS, COMPOSITIONS, AND METHODS FOR INDUCING IMMUNE RESPONSE

    OREGON HEALTH & SCIENCE UNIVERSITY

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  25. JP 2023511858-A2023-03-23

    Expression of ovalbumin and its natural variants

    The Protein Brewery B V

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   258 SIINFEKL 265
    

    8 of 8 identical, no gaps.

  26. JP 2023512526-A2023-03-27

    COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING HEPATITIS B AND D

    Svenska Vaccinfabriken Produktion AB

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  27. JP 2023512670-A2023-03-28

    Cancer Immunotherapy Using Transfusions Of Allogeneic, Tumor-Specific CD4+ T Cells

    THE JOHNS HOPKINS UNIVERSITY,Ephraim Joseph FUCHS,Heather Jill SYMONS, Lode SWINNEN

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  28. US 11612651-B22023-03-28

    Steroid acid-based immunogen enhancers

    DEFENCE THERAPEUTICS INC.

    Query Match 100.0%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  29. US 11612652-B22023-03-28

    Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy

    PDS Biotechnology Corporation

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 18 to 25. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   18 SIINFEKL 25
    

    8 of 8 identical, no gaps.

  30. Novel vaccine platform based on Reovirus and the use thereof

    ViroCure, Inc

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 21 to 28. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   21 SIINFEKL 28
    

    8 of 8 identical, no gaps.

  31. MULTIEPITOPE VACCINE CASSETTES

    GRITSTONE BIO, INC

    Query Match 100.0%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 8, hit 37 to 44. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   37 SIINFEKL 44
    

    8 of 8 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  32. JP 2023052647-A2023-04-11

    Patent application sequence for JP 2023052647-A/10

    Julius-Maximilians-Universitaet Wuerzburg

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  33. US 11623945-B22023-04-11

    Immunostimulating compositions and uses therefore

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   258 SIINFEKL 265
    

    8 of 8 identical, no gaps.

  34. POLYNUCLEOTIDES COMPRISING AN ANTIGENIC PAYLOAD

    NUTCRACKER THERAPEUTICS, INC

    Query Match 100.0%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 3

    Grouped by a shared priority claim, US 63/024604.

  35. JP 2023515671-A2023-04-13

    METHODS AND COMPOSITIONS FOR SENSITIZATION OF TUMOR CELLS TO IMMUNE THERAPY

    REGENERON PHARMACEUTICALS INC

    Query Match 100.0%Identity 100.0%Family of 4

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 4

    Grouped by a shared priority claim, US 62/985004.

  36. US 11628218-B22023-04-18

    Engineered chimeric fusion protein compositions and methods of use thereof

    MYELOID THERAPEUTICS, INC.

    Query Match 100.0%Identity 100.0%Family of 4

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 4

    Grouped by the same title and applicant. No priority claim is on record.

  37. B-CELL BASED IMMUNOTHERAPY FOR THE TREATMENT OF GLIOBLASTOMA AND OTHER CANCERS

    NORTHWESTERN UNIVERSITY

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  38. US 11638753-B22023-05-02

    Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy

    PDS Biotechnology Corporalion

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 18 to 25. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   18 SIINFEKL 25
    

    8 of 8 identical, no gaps.

  39. JP 2023518809-A2023-05-08

    METHOD OF ENGINEERING AND ISOLATING ADENO-ASSOCIATED VIRUS

    DIGNITY HEALTH,Fredric MANFREDSSON,Ivette SANDOVAL

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  40. MODIFIED MYCOBACTERIUM BOVIS VACCINES

    Valo Therapeutics Oy

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 6 to 13. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit    6 SIINFEKL 13
    

    8 of 8 identical, no gaps.

  41. IMMUNOSTIMULATORY BACTERIA-BASED VACCINES, THERAPEUTICS, AND RNA DELIVERY PLATFORMS

    ACTYM THERAPEUTICS, INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  42. US 11648306-B22023-05-16

    Non-integrative listeria-based vaccine and method for inducing antitumor immune response

    Suzhou RoyalTech Med CO., Ltd and Shanghai RoyalTech Med CO., Ltd

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 11 to 18. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   11 SIINFEKL 18
    

    8 of 8 identical, no gaps.

  43. US 11649436-B22023-05-16

    Exosome for stimulating T cell and pharmaceutical use thereof

    THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  44. HETEROLOGOUS PRIME BOOST VACCINE

    BOEHRINGER INGELHEIM INTERNATIONAL GMBH

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 132 to 139. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   132 SIINFEKL 139
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  45. US 11654188-B22023-05-23

    Glycotargeting therapeutics

    Ecole Polytechnique Federale de Lausanne (EPFL) and Anokion, SA

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 257 to 264. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   257 SIINFEKL 264
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  46. US 11655483-B22023-05-23

    Use of novel miRNA-binding site cassettes for antigen-presenting cell detargeting of transgene expression by rAAV gene therapy vectors

    University of Massachusetts

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  47. JP 2023521662-A2023-05-25

    INFECTIOUS DISEASE ANTIGENS AND VACCINES

    GRITSTONE BIO INC

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 37 to 44. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   37 SIINFEKL 44
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  48. JP 2023523413-A2023-06-05

    ANTIGEN-ENCODING CASSETTES

    GRITSTONE BIO INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 34 to 41. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   34 SIINFEKL 41
    

    8 of 8 identical, no gaps.

  49. JP 2023523414-A2023-06-05

    CAPPING COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF

    GRITSTONE BIO INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 37 to 44. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   37 SIINFEKL 44
    

    8 of 8 identical, no gaps.

  50. LFA-1 SIGNALLING MEDIATOR FOR USE IN CANCER THERAPY

    UNIVERSITAT BASEL

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.